Effect of long-term streptozotocin-induced diabetes on coronary vasoconstriction in isolated perfused rat heart

Journal of Smooth Muscle Research

Volumn 44, Issue 5, 2008, Pages 177-188

  Kamata, Katsuo ^a   Ozawa, Yuta ^a   Kobayashi, Tsuneo ^a   Matsumoto, Takayuki ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Coronary artery; Diabetes; Perfusion pressure; Rat; Streptozotocin

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACETYLCHOLINE; CALCIUM CHANNEL STIMULATING AGENT; ENDOTHELIN 1; POTASSIUM; VASOCONSTRICTOR AGENT;

ANIMAL; ARTICLE; CORONARY BLOOD VESSEL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; IN VITRO STUDY; MALE; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; RAT; TIME; VASOCONSTRICTION; WISTAR RAT;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ACETYLCHOLINE; ANIMALS; CALCIUM CHANNEL AGONISTS; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIN-1; MALE; PERFUSION; POTASSIUM; RATS; RATS, WISTAR; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 58149517909     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.44.177     Document Type: Article

References (63)

1. Bax, J.J., Young, L.H., Frye, R.L., Bonow, R.O., Steinberg, H.O. and Barrett, E.J; ADA. (2007). Screening for coronary artery disease in patients with diabetes. Diabetes Care 30: 2729-2736.
2. Brunner, F., Bras-Silva, C., Cerdeira, A.S. and Leite-Moreira, A.F. (2006). Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol. Ther. 111: 508-531.
3. Chang, K.S. and Stevens, W.C. (1992). Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br. J. Pharmacol. 107: 983-990.
4. De Vriese, A.S., Verbeuren, T.J., Van de Voorde, J., Lameire, N.H. and Vanhoutte, P.M. (2000). Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130: 963-974.
5. Dubrey, S.W., Reaveley, D.R., Seed, M., Lane, D.A., Ireland, H., O'Donnell, M., O'Connor, B., Noble, M.I. and Leslie, R.D. (1994). Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes 43: 831-835.
6. Durante, W., Sunahara, F.A. and Sen, A.K. (1989). Effect of diabetes on metabolic coronary dilatation in the rat. Cardiovasc. Res. 23: 40-45.
7. Egashira, K., Suzuki, S., Hirooka, Y., Kai, H., Sugimachi, M., Imaizumu, T. and Takeshita, A. (1995). Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25: 201-206.
8. Feigl, E.O. (1998). Neural control of coronary blood flow. J. Vasc. Res. 35: 85-92.
9. Fein, F.S. and Sonnenblick, E.H. (1985). Diabetic cardiomyopathy. Prog. Cardiovasc. Dis. 27: 255-270.
10. Fukuda, K., Hori, S., Kusuhara, M., Satoh, T., Kyotani, S., Handa, S., Nakamura, Y., Oono, H. and Yamaguchi, K. (1989). Effect of endothelin as a coronary vasoconstrictor in the Langendorff-perfused rat heart. Eur. J. Pharmacol. 165: 301-304.
11. Goto, K., Hama, H. and Kasuya, Y. (1996). Molecular pharmacology and pathophysiological significance of endothelin. Jpn. J. Pharmacol. 72: 261-290.
12. 2+ channel in vascular smooth muscle. Proc. Natl. Acad. USA. 86: 3915-3918.
13. Hess, P., Lansman, J.B. and Tsien, R.W. (1984). Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature 311: 538-544.
14. Hodgson, J.M. and Marshall, J.J. (1989). Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 79: 1043-1051.
15. Hoover, D.B. and Neely, D.A. (1997). Differentiation of muscarinic receptors mediating negative chronotropic and vasoconstrictor responses to acetylcholine in isolated rat hearts. J. Pharmacol. Exp. Ther. 282: 1337-1344.
16. Inazu, M., Sakai, Y. and Homma, I. (1991). Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur. J. Pharmacol. 203: 79-84.
17. Kalsner, S. (1989). Cholinergic constriction in the general circulation and its role in coronary artery spasm. Circ. Res. 65: 237-257.
18. Kamata, K., Miyata, N., Abiru, T. and Kasuya, Y. (1992). Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 50: 1379-1387.
19. Kamata, K., Miyata, N. and Kasuya, Y. (1989). Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97: 614-618.
20. Kamata, K., Hosokawa, M., Matsumoto, T. and Kobayashi, T. (2006). Acetylcholine-induced vasodilation in the perfused kidney of the streptozotocin-induced diabetic rat: role of prostacyclin. J. Smooth Muscle Res. 42: 159-170.
21. Kanie, N. and Kamata, K. (2002). Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat. Br. J. Pharmacol. 135: 1935-1942.
22. Kanmura, Y., Itoh, T. and Kuriyama, H. (1984). Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery. J. Pharmacol. Exp. Ther. 231: 717-723.
23. Karaki, H., Ozaki, H., Hori, M., Mitsui-Saito, M., Amano, K., Harada, K., Miyamoto, S., Nakazawa, H., Won, K.J. and Sato, K. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49: 157-230.
24. Kawamura, A., Fujiwara, H., Onodera, T., Wu, D.J., Matsuda, M., Ishida, M., Takemura, G., Fujiwara, Y. and Kawai, C. (1989). Response of large and small coronary arteries of pigs to intracoronary injection of acetylcholine: angiographic and histologic analysis. Int. J. Cardiol. 25: 289-302.
25. Kobayashi, T. and Kamata, K. (1999). Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br. J. Pharmacol. 127: 835-842.
26. Kobayashi, T., Matsumoto, T. and Kamata, K. (2000). Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 131: 231-238.
27. Kobayashi, T., Matsumoto, T. and Kamata, K. (2005). The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models. J. Smooth Muscle Res. 41: 283-302.
28. Kobayashi, T., Oishi, K., Hayashi, Y., Matsumoto, T. and Kamata, K. (2006). Changes in aortic endothelial gene expressions and relaxation responses following chronic short-term insulin treatment in diabetic rats. Atherosclerosis 185: 47-57.
29. Koshita, M., Hidaka, K., Ueno, H., Yamamoto, Y. and Suzuki, H. (2007). Properties of acetylcholine-induced hyperpolarization in smooth muscle cells of the mouse mesenteric artery. J. Smooth Muscle Res. 43: 219-227.
30. Luscher, T.F., Boulanger, C.M., Dohi, Y. and Yang, Z.H. (1992). Endothelium-derived contracting factors. Hypertension 1992: 117-130.
31. MacLeod, K.M. and McNeill, J.H. (1985). The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Can. J. Physiol. Pharmacol. 63: 52-57.
32. Makino, A. and Kamata, K. (1998). Elevated plasma endothelin-1 level in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br. J. Pharmacol. 123: 1065-1072.
33. Matsumoto, T., Kobayashi, T. and Kamata, K. (2003a). Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 285: H283-H291.
34. Matsumoto, T., Kobayashi, T. and Kamata, K. (2003b). Phosphodiesterases in the vascular system. J. Smooth Muscle Res. 39: 67-86.
35. Matsumoto, T., Kobayashi, T. and Kamata, K. (2006a). A therapeutic target for microvascular complications in diabetes: endothelium-derived hyperpolarizing factor. Curr. Cardiol. Rev. 2: 185-191.
36. Matsumoto, T., Kobayashi, T. and Kamata, K. (2008). Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. J. Smooth Muscle Res. 44: 41-55.
37. Matsumoto, T., Kobayashi, T., Wakabayashi, K. and Kamata, K. (2005). Cilostazol improves endothelium-derived hyperpolarizing factor-type relaxation in mesenteric arteries from diabetic rats. Am. J. Physiol. Heart Circ. Physiol. 289: H1933-H1940.
38. Matsumoto, T., Miyamori, K., Kobayashi, T. and Kamata, K. (2006b). Apocynin normalizes hyperreactivity to phenylephrine in mesenteric arteries from cholesterol-fed mice by improving endothelium-derived hyperpolarizing factor response. Free Radic. Biol. Med. 41: 1289-1303.
39. Matsumoto, T., Noguchi, E., Kobayashi, T. and Kamata, K (2007). Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. Free Radic. Biol. Med. 42: 993-1007.
40. Miki, S., Takeda, K., Kiyama, M., Hatta, T., Morimoto, S., Kawa, T., Itoh, H., Nakata, T., Sasaki, S. and Nakagawa, M. (1998). Augmented response of endothelin-A and endothelin-B receptor stimulation in coronary arteries of hypertensive hearts. J. Cardiovasc. Pharmacol. 31: S94-S98.
41. 2+ entry channels involved in endothelin-1-induced contractions of vascular smooth muscle cells. J. Smooth Muscle Res. 41: 61-75.
42. Miyauchi, T. and Masaki, T. (1999). Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61: 391-415.
43. Muramatsu, K., Tomoike, H., Ohara, Y., Egashira, S. and Nakamura, M. (1991). Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs. Heart Vessels 6: 191-196.
44. Oyama, Y., Kawasaki, H., Hattori, Y. and Kanno, M. (1986). Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur. J. Pharmacol. 132: 75-78.
45. Pernow, J. and Wang, O.D. (1997). Endothelin in myocardial ischemia and reperfusion. Cardiovasc. Res. 33: 518-526.
46. Pieper, G.M. (1999). Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia. 42: 204-213.
47. Pollock, D.M., Keith, T.L. and Highsmith, R.F. (1995). Endothelin receptors and calcium signaling. FASEB J. 9: 1196-1204.
48. Poston, L. and Taylor, P.D. (1995). Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. 88: 251-252.
49. Rodriguez-Manas, L., Angulo, J., Peiro, C., Llergo, J.L., Sanchez-Ferrer, A., Lopez-Doriga, P. and Snchez-Ferrer, C.F. (1998). Endothelial dysfunction and metabolic control in streptozotocin-induced diabetic rats. Br. J. Pharmacol. 123: 1495-1502.
50. Rubanyi, G.M. and Polokoff, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46: 325-415.
51. Sakai, K. (1980). Coronary vasoconstriction by locally administered acetylcholine, carbachol and bethanechol in isolated, donor-perfused, rat hearts. Br. J. Pharmacol. 68: 625-632.
52. Schneider, J.G., Tilly, N., Hierl, T., Sommer, U., Hamann, A., Dugi, K., Leidig-Bruckner, G. and Kasperk, C. (2002). Elevated plasma endothelin-1 levels in diabetes mellitus. Am. J. Hypertens. 15: 967-972.
53. Stewart, D.J., Kubac, G., Costello, K.B. and Cernacek, P. (1991). Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18: 38-43.
54. Tickerhoof, M.M., Farrell, P.A. and Korzick, D.H. (2003). Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes. Am. J. Physiol. 285: H2694-H2703.
55. Tomlinson, K.C., Gardiner, S.M., Hebden, R.A. and Bennett, T. (1992). Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol. Rev. 44: 103-150.
56. Toyo-oka, T., Aizawa, T., Suzuki, N., Hirata, Y., Miyauchi, T., Shin, W.S., Yanagisawa, M., Masaki, T. and Sugimoto, T. (1991). Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483.
57. Treasure, C.B., Manoukian, S.V., Klein, J.L., Vita, J.A., Nabel, E.G., Renwick, G.H., Selwyn, A.P., Alexander, R.W. and Ganz, P. (1992). Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ. Res. 71: 776-781.
58. Vadlamudi, R.V. and McNeill, J.H. (1983). Effect of alloxan- and streptozotocin-induced diabetes on isolated rat heart responsiveness to carbachol. J. Pharmacol. Exp. Ther. 225: 410-415.
59. Van Charldorp, K.J., De Jonge, A., Davidesko, D., Rinner, I., Doods, H.N. and Van Zwieten, P.A. (1987). Coronary constriction induced by vagal stimulation in the isolated rat heart. Eur. J. Pharmacol. 136: 135-136.
60. Verma, S., Arikawa, E., Lee, S., Dumont, A.S., Yao, L. and McNeill, J.H. (2002). Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan. Can. J. Physiol. Pharmacol. 80: 980-986.
61. Weselcouch, E.O., Baird, A.J., Sleph, P. and Grover, G.J. (1995). Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am. J. Physiol. 268: H242-H249.
62. White, R.E. and Carrier, G.O. (1990). Vascular contraction induced by activation of membrane calcium ion channels is enhanced in streptozotocin-diabetes. J. Pharmacol. Exp. Ther. 253: 1057-1062.
63. Zhang, Y. and Hoover, D.B. (2000). Signaling mechanisms for muscarinic receptor-mediated coronary vasoconstriction in isolated rat hearts. J. Pharmacol. Exp. Ther. 293: 96-106.